FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ

Lance A. Stechschulte, Terry D. Hinds, Saja S. Khuder, Weinian Shou, Sonia M. Najjar, Edwin R. Sanchez

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Glucocorticoid receptor-α (GRα) and peroxisome proliferator-activated receptor-γ (PPARγ) are critical regulators of adipogenic responses.Wehave shown that FK506-binding protein 51 (FKBP51) represses the Akt-p38 kinase pathway to reciprocally inhibit GRα but stimulate PPARγ by targeting serine 112 (PPARγ) and serines 220 and 234 (GRα). Here, this mechanism is shown to be essential for GRα and PPARγ control of cellular adipogenesis. In 3T3-L1 cells, FKBP51 was a prominent marker of the differentiated state and knockdown of FKBP51 showed reduced lipid accumulation and expression of adipogenic genes. Compared with wild-type (WT), FKBP51 knockout (51KO) mouse embryonic fibroblasts (MEFs) showed dramatic resistance to differentiation, with almost no lipid accumulation and greatly reduced adipogenic gene expression. These features were rescued by reexpression of FKBP51 in 51KO cells. 51KO MEFs exhibited reduced fatty acid synthase activity, increased sensitivity to GRα-induced lipolysis, and reduced PPARγ activity at adipogenic genes (adiponectin, CD36, and perilipin) but elevated GRα transrepression at these same genes. A p38 kinase inhibitor increased lipid content in WT cells and also restored lipid levels in 51KO cells, showing that elevated p38 kinase activity is a major contributor to adipogenic resistance in the51KOcells. In51KOcells, the S112A mutant of PPARγand the triple S212A/S220A/S234A mutant of GRα both increased lipid accumulation, identifying these residues as targets of the FKBP51/p38 axis. Our combined investigations have uncovered FKBP51 as a key regulator of adipogenesis via the Akt-p38 pathway and as a potential target in the treatment of obesity and related disorders.

Original languageEnglish
Pages (from-to)1265-1275
Number of pages11
JournalMolecular Endocrinology
Volume28
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Tacrolimus Binding Proteins
Adipogenesis
Peroxisome Proliferator-Activated Receptors
Glucocorticoid Receptors
Phosphotransferases
Phosphorylation
Lipids
Serine
Fibroblasts
3T3-L1 Cells
Gene Expression
Fatty Acid Synthases
MAP Kinase Signaling System
Lipolysis
Adiponectin
Knockout Mice
Genes
Obesity

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology
  • Medicine(all)

Cite this

FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ. / Stechschulte, Lance A.; Hinds, Terry D.; Khuder, Saja S.; Shou, Weinian; Najjar, Sonia M.; Sanchez, Edwin R.

In: Molecular Endocrinology, Vol. 28, No. 8, 2014, p. 1265-1275.

Research output: Contribution to journalArticle

Stechschulte, Lance A. ; Hinds, Terry D. ; Khuder, Saja S. ; Shou, Weinian ; Najjar, Sonia M. ; Sanchez, Edwin R. / FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ. In: Molecular Endocrinology. 2014 ; Vol. 28, No. 8. pp. 1265-1275.
@article{f3e268854b844f5cb4e5437d03c4e132,
title = "FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ",
abstract = "Glucocorticoid receptor-α (GRα) and peroxisome proliferator-activated receptor-γ (PPARγ) are critical regulators of adipogenic responses.Wehave shown that FK506-binding protein 51 (FKBP51) represses the Akt-p38 kinase pathway to reciprocally inhibit GRα but stimulate PPARγ by targeting serine 112 (PPARγ) and serines 220 and 234 (GRα). Here, this mechanism is shown to be essential for GRα and PPARγ control of cellular adipogenesis. In 3T3-L1 cells, FKBP51 was a prominent marker of the differentiated state and knockdown of FKBP51 showed reduced lipid accumulation and expression of adipogenic genes. Compared with wild-type (WT), FKBP51 knockout (51KO) mouse embryonic fibroblasts (MEFs) showed dramatic resistance to differentiation, with almost no lipid accumulation and greatly reduced adipogenic gene expression. These features were rescued by reexpression of FKBP51 in 51KO cells. 51KO MEFs exhibited reduced fatty acid synthase activity, increased sensitivity to GRα-induced lipolysis, and reduced PPARγ activity at adipogenic genes (adiponectin, CD36, and perilipin) but elevated GRα transrepression at these same genes. A p38 kinase inhibitor increased lipid content in WT cells and also restored lipid levels in 51KO cells, showing that elevated p38 kinase activity is a major contributor to adipogenic resistance in the51KOcells. In51KOcells, the S112A mutant of PPARγand the triple S212A/S220A/S234A mutant of GRα both increased lipid accumulation, identifying these residues as targets of the FKBP51/p38 axis. Our combined investigations have uncovered FKBP51 as a key regulator of adipogenesis via the Akt-p38 pathway and as a potential target in the treatment of obesity and related disorders.",
author = "Stechschulte, {Lance A.} and Hinds, {Terry D.} and Khuder, {Saja S.} and Weinian Shou and Najjar, {Sonia M.} and Sanchez, {Edwin R.}",
year = "2014",
doi = "10.1210/me.2014-1022",
language = "English",
volume = "28",
pages = "1265--1275",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ

AU - Stechschulte, Lance A.

AU - Hinds, Terry D.

AU - Khuder, Saja S.

AU - Shou, Weinian

AU - Najjar, Sonia M.

AU - Sanchez, Edwin R.

PY - 2014

Y1 - 2014

N2 - Glucocorticoid receptor-α (GRα) and peroxisome proliferator-activated receptor-γ (PPARγ) are critical regulators of adipogenic responses.Wehave shown that FK506-binding protein 51 (FKBP51) represses the Akt-p38 kinase pathway to reciprocally inhibit GRα but stimulate PPARγ by targeting serine 112 (PPARγ) and serines 220 and 234 (GRα). Here, this mechanism is shown to be essential for GRα and PPARγ control of cellular adipogenesis. In 3T3-L1 cells, FKBP51 was a prominent marker of the differentiated state and knockdown of FKBP51 showed reduced lipid accumulation and expression of adipogenic genes. Compared with wild-type (WT), FKBP51 knockout (51KO) mouse embryonic fibroblasts (MEFs) showed dramatic resistance to differentiation, with almost no lipid accumulation and greatly reduced adipogenic gene expression. These features were rescued by reexpression of FKBP51 in 51KO cells. 51KO MEFs exhibited reduced fatty acid synthase activity, increased sensitivity to GRα-induced lipolysis, and reduced PPARγ activity at adipogenic genes (adiponectin, CD36, and perilipin) but elevated GRα transrepression at these same genes. A p38 kinase inhibitor increased lipid content in WT cells and also restored lipid levels in 51KO cells, showing that elevated p38 kinase activity is a major contributor to adipogenic resistance in the51KOcells. In51KOcells, the S112A mutant of PPARγand the triple S212A/S220A/S234A mutant of GRα both increased lipid accumulation, identifying these residues as targets of the FKBP51/p38 axis. Our combined investigations have uncovered FKBP51 as a key regulator of adipogenesis via the Akt-p38 pathway and as a potential target in the treatment of obesity and related disorders.

AB - Glucocorticoid receptor-α (GRα) and peroxisome proliferator-activated receptor-γ (PPARγ) are critical regulators of adipogenic responses.Wehave shown that FK506-binding protein 51 (FKBP51) represses the Akt-p38 kinase pathway to reciprocally inhibit GRα but stimulate PPARγ by targeting serine 112 (PPARγ) and serines 220 and 234 (GRα). Here, this mechanism is shown to be essential for GRα and PPARγ control of cellular adipogenesis. In 3T3-L1 cells, FKBP51 was a prominent marker of the differentiated state and knockdown of FKBP51 showed reduced lipid accumulation and expression of adipogenic genes. Compared with wild-type (WT), FKBP51 knockout (51KO) mouse embryonic fibroblasts (MEFs) showed dramatic resistance to differentiation, with almost no lipid accumulation and greatly reduced adipogenic gene expression. These features were rescued by reexpression of FKBP51 in 51KO cells. 51KO MEFs exhibited reduced fatty acid synthase activity, increased sensitivity to GRα-induced lipolysis, and reduced PPARγ activity at adipogenic genes (adiponectin, CD36, and perilipin) but elevated GRα transrepression at these same genes. A p38 kinase inhibitor increased lipid content in WT cells and also restored lipid levels in 51KO cells, showing that elevated p38 kinase activity is a major contributor to adipogenic resistance in the51KOcells. In51KOcells, the S112A mutant of PPARγand the triple S212A/S220A/S234A mutant of GRα both increased lipid accumulation, identifying these residues as targets of the FKBP51/p38 axis. Our combined investigations have uncovered FKBP51 as a key regulator of adipogenesis via the Akt-p38 pathway and as a potential target in the treatment of obesity and related disorders.

UR - http://www.scopus.com/inward/record.url?scp=84905245970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905245970&partnerID=8YFLogxK

U2 - 10.1210/me.2014-1022

DO - 10.1210/me.2014-1022

M3 - Article

VL - 28

SP - 1265

EP - 1275

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 8

ER -